What is INCY stock price today?

Visit our real-time dashboard for the current INCY stock price and live market data.

Is INCY stock going up or down today?

INCY stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy INCY stock now?

The decision to buy INCY depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is INCY a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for INCY based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is INCY stock overvalued or undervalued?

INCY currently trades at a P/E ratio of 14.46, which may suggest attractive valuation. Our DCF calculator provides intrinsic value estimates to help determine if INCY is fairly priced.

What is INCY's P/E ratio?

INCY has a price-to-earnings (P/E) ratio of 14.46, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is INCY's market cap?

INCY (Incyte Corporation) has a market capitalization of $20.45 billion, making it a mid-cap stock.

What is INCY's price to book ratio?

Price-to-book ratio for INCY is available on our dashboard along with other valuation metrics.

Does INCY pay dividends?

INCY does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is INCY's dividend yield?

INCY does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is INCY stock a good long-term investment?

INCY's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is INCY's revenue growth rate?

Revenue growth data for INCY is available on our dashboard with detailed financial statement analysis.

Profitability metrics for INCY are available on our dashboard with complete income statement analysis.

What are the risks of investing in INCY?

Key risks for INCY include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does INCY compare to its competitors?

Compare INCY to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize INCY's performance and positioning.

What is INCY's stock price target for 2026?

Visit our prediction page for AI-powered price targets for INCY with bull, base, and bear case scenarios.

What do analysts say about INCY?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for INCY. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is INCY's next earnings report?

INCY reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

INCY - Incyte Corporation

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+0.00%)

About Incyte Corporation

Incyte Corporation (INCY) common stock

Price Chart

Loading chart...

INCY Key Statistics

Market Cap

$20.45B

P/E Ratio

14.46

How INCY Compares to Peers

INCY ranks 2nd most undervalued by P/E ratio among peers

INCY is the smallest among peers, which may offer higher growth potential

P/E Rank

of 6

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
INCY(This stock)	$20.45B	14.5	0%	0.0%	-
AMGNAmgen Inc	$188.67B	24.3	0%	0.0%	vs AMGN
GILDGilead Sciences	$160.15B	17.5	0%	0.0%	vs GILD
VRTXVertex Pharmaceuticals	$106.87B	29.7	0%	0.0%	vs VRTX
REGNRegeneron Pharmaceuticals	$59.10B	13.9	0%	0.0%	vs REGN
BIIBBiogen Inc	$29.33B	21.4	0%	0.0%	vs BIIB

Data Updated: July 16, 2026 at 4:21 PM EDT

Ready to invest in INCY?

Commission-free trading available. Affiliate links.

INCY Lician Score

10% confidence

6.0/10

Good

INCY has a Lician Score of 6/10 (Good). Strengths: Growth.

value

5.0

growth

8.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates INCYacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

INCY Financial Snowflake

5-axis analysis across key investment dimensions

5.6/10

Neutral

5.0

Value

Valuation vs. sector peers

8.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for INCY

Dashboard

Enter a ticker to analyze